Clinical Trial Update: NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for NALDEBAIN in postoperative pain management following take down of anastomosis; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Naldebain (dinalbuphine ester)

Snippet

Sponsor: China Medical University Hospital | Conditions: Postoperative Pain | Phase 4 | Status: UNKNOWN